Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

RNA Polymerase II Accessory Proteins

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The dual-coding gene SLC35A4 protects against oxidative stress.

Protein science : a publication of the Protein Society·2025

Same author

The CHARGE syndrome-associated protein FAM172A controls AGO2 nuclear import.

Life science alliance·2023

Same author

CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma.

Nature communications·2022

Same author

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Nature communications·2022

Same author

Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.

Frontiers in immunology·2022

Same author

NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay.

Cell reports·2020

Search research articles

Related Experiment Video

Updated: May 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.

Nathalie Girard¹, Mathieu Tremblay, Magali Humbert

¹Institute of Research in Immunology and Cancer (IRIC), Molecular Biology Program, and Department of Pharmacology, University of Montreal, Montreal, QC, Canada H3C 3J7.

Proceedings of the National Academy of Sciences of the United States of America

|July 31, 2013

Summary

The RARα-PLZF fusion protein in t(11;17) acute promyelocytic leukemia impairs granulocytic differentiation by inhibiting the master regulator C/EBPα. HDAC inhibitors partially restore C/EBPα target gene expression.

Keywords:

APL granulocyte differentiation histone modification protein interaction transcription inhibition

More Related Videos

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Experiment Videos

Last Updated: May 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Area of Science:

Hematology
Molecular Biology
Cancer Research

Background:

Acute promyelocytic leukemia (APL) is characterized by blocked granulocytic differentiation.
The t(11;17) translocation in APL generates PLZF-RARα and RARα-PLZF fusion proteins.
CCAAT/enhancer binding protein α (C/EBPα) is crucial for myeloid differentiation.

Purpose of the Study:

To investigate the mechanism by which the RARα-PLZF fusion protein affects C/EBPα activity in t(11;17) APL.
To compare the impact of t(11;17) with t(15;17) translocations on C/EBPα function.
To explore therapeutic strategies targeting C/EBPα inhibition.

Main Methods:

Chromatin immunoprecipitation (ChIP) assays to assess protein-DNA interactions.
DNA capture assays to identify protein binding partners.
Histone deacetylase (HDAC) activity assays.
Analysis of C/EBPα target gene expression.

Main Results:

RARα-PLZF directly interacts with C/EBPα bound to DNA, inhibiting its function.
RARα-PLZF recruits HDAC1 to C/EBPα target loci, leading to histone deacetylation.
This epigenetic modification reduces the expression of C/EBPα-regulated genes essential for differentiation.
HDAC inhibitors partially reversed the suppression of C/EBPα target genes.

Conclusions:

RARα-PLZF acts as a modifier oncogene by disrupting C/EBPα-mediated granulocytic differentiation.
The interaction between RARα-PLZF and C/EBPα, along with HDAC recruitment, is a key mechanism of leukemogenesis in t(11;17) APL.
Targeting HDAC activity may offer a potential therapeutic approach for this subtype of APL.